Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 21, 2015Science Translational Medicine

Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

RLRui LiFujian University of Traditional Chinese MedicineARAyman RezkUniversity of PennsylvaniaYMYusei MiyazakiNational Hospital Organization Hokkaido Medical Center

Discussion

Loading...

Member takes

Overview

Mechanistic study reveals elevated GM-CSF-producing B cells activate myeloid cells in multiple sclerosis, indicating that B cell depletion therapy restores cytokine balance to curb inflammation.

Key Points

  • To identify the pathogenic role and regulatory mechanisms of GM-CSF-producing B cell subsets in multiple sclerosis and determine how B cell depletion therapy impacts their function.
  • Analyzed frequency and in vitro induction of GM-CSF-expressing memory B cells from multiple sclerosis patients compared with healthy controls.
  • Assessed myeloid cell activation in vitro and profiled proinflammatory myeloid responses in vivo before and after B cell depletion therapy.
  • Investigated the role of STAT5 and STAT6 signaling in regulating the balance between GM-CSF and IL-10 cytokine production during B cell reconstitution.
  • Memory B cells expressing GM-CSF were significantly more frequent in patients with multiple sclerosis and activated myeloid cells in a GM-CSF-dependent manner.
  • Enhanced STAT5 and STAT6 signaling in untreated patients drove GM-CSF production while reciprocally suppressing regulatory IL-10 expression in B cells.
  • B cell depletion therapy normalized STAT5/6 signaling and the GM-CSF/IL-10 secretion ratio, maintaining reduced proinflammatory myeloid responses even after B cell repopulation.

Cite This Study

Li et al. (2015) studied this question.

synapsesocial.com/papers/6a7ccea9469490254d190c8fhttps://doi.org/10.1126/scitranslmed.aab4176
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Systems Analysis of Immune Changes after B-cell Depletion in Autoimmune Multiple Sclerosis2024 · 5 citations
  2. 2Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis2026
  3. 3<scp>CD11c</scp><sup>+</sup> B cells in relapsing–remitting multiple sclerosis and effects of <scp>anti‐CD20</scp> therapy2024 · 10 citations
  4. 4Reduced BCMA Signaling Disrupts the BAFF/APRIL Axis and Promotes Inflammatory Cytokine Production by B Cells in Multiple Sclerosis 22585732026
  5. 5Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosis2024 · 48 citations